Cubist Investor Relations

Building Long-term Shareholder Value

• View the June 11, 2012 Investor Day Presentation by our CEO & President Mike Bonney: Building Blocks of Growth – Cubist 5 Year Goals
• View the June 11, 2012 Investor Day Presentation by our EVP & Chief Scientific Officer Steve Gilman: Cubist Differentiated Pipeline Development Strategy
• View the June 11, 2012 Investor Day Presentations on all of our clinical stage programs here

What's next for Cubist?

Cubist is moving forward confidently and successfully as an acute care-focused therapeutics company

Our most recent financial results were announced on April 18, 2013.

• View our most recent 1Q13 Earnings Release
• View our most recent 1Q13 Earnings Presentation
• View our most recent 1Q13 Investor Presentation
• View our most recent 1Q13 non-GAAP Reconciliation


• View our most recent 4Q12/FY non-GAAP Reconciliation

Click Here to receive more information from Cubist Pharmaceuticals